Back

Xenon grants 13,450 options and 7,850 RSUs to five employees

Verifying
  • Xenon Pharmaceuticals granted equity awards to five new non-officer employees.
  • 13,450 options and 7,850 RSUs were awarded at an option price of $61.93.
  • The Compensation Committee approved the inducements effective Aug. 27, 2026, under Nasdaq rules.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.